Metagenomi Inc. (MGX) - Pendapatan reged perusahaan

metagenomi.co - logo grafis emiten MGX

Metagenomi, Inc. (MGX) is building the foundation of future medicine by combining AI and computational libraries to discover gene-editing tools. Gross sales revenue for the company, as shown in the GURU.Markets chart, indicates that the metric value is 0.01. The business relies on a massive array of CRISPR enzymes for DNA therapy, although current earnings are limited solely to research partnerships.

Metagenomi, Inc. (MGX) - Pendapatan lan volume dodolan saka 21.02.2024 nganti 17.11.2026

Rincian metrik komprehensif lan analitis Metagenomi Therapeutics (MGX)

- nilai saham lan prakiraan konsensus rega:
Analisis umum perusahaan:Metagenomi, Inc.
Sampel barang Metagenomi, Inc

Metagenomi, Inc. (MGX) is scaling its genome editing developments through strategic alliances with pharmaceutical behemoths. The company's total sales on the GURU.Markets platform capture a daily revenue inflow, reflecting real market demand for innovation. This metric measures operational efficiency and the monetization speed of the pipeline in oncology and genetics. The steady growth of this indicator confirms the viability of the business model and reduces early-stage investment risks.

Analisis perusahaan pesaing

Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Dodolan perusahaan QGEN (Qiagen NV)|Pendapatan lan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Pendapatan lan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Total pendapatan perusahaan|CRSP - Pendapatan perusahaan|Pendapatan reged perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Pendapatan perusahaan|Total pendapatan perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Twist Bioscience Corp TWST|Pendapatan lan volume dodolan TXG|Pendapatan lan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Dodolan perusahaan|BioLife Solutions Inc (BLFS) - Total pendapatan perusahaan|wavelifesciences.com - Pendapatan lan volume dodolan|Maze Therapeutics Corp (MAZE) - Dodolan perusahaan|SION: Pendapatan lan volume dodolan|Volume dodolan perusahaan PRME|Pendapatan perusahaan Taysha Gene Therapies|Volume dodolan perusahaan QURE (uniQure)|Pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Volume dodolan perusahaan|Pendapatan perusahaan Solid Biosciences SLDB|OCGN - Dodolan perusahaan|pacb.com - Pendapatan lan volume dodolan|Benitec (BNTC) - Dodolan perusahaan|DSGN: Pendapatan lan volume dodolan|RCKT - Pendapatan reged perusahaan|FDMT: Pendapatan reged perusahaan|Volume dodolan perusahaan LXEO (lexeotx.com)|Pendapatan perusahaan Korro Bio Inc. (KRRO)|Total dodolan perusahaan EDIT|Pendapatan lan volume dodolan SLN (Silence Therapeutics PLC)|Pendapatan dodolan perusahaan PRQR|CDXS - Pendapatan perusahaan|SGMO (Sangamo Therapeutics) - Volume dodolan perusahaan|NAUT: Pendapatan lan volume dodolan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan